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Abstract 
 
Background: Despite the relationship of idiopathic pulmonary fibrosis (IPF) with advancing age, little is 
known about the epidemiology of interstitial lung diseases (ILD) in the elderly. Here we describe the 
diagnoses, clinical characteristics, and outcomes of patients who were elderly at the time of ILD 
diagnosis.   
Methods: Among subjects from a prospective cohort study of ILD, elderly was defined as age > 70. 
Diagnoses were derived from a multi-disciplinary review. Differences between elderly and non-elderly 
groups were determined using chi-square and ANOVA testing.   
Results: Of the 327 subjects enrolled, 80 (24%) were elderly. The majority of elderly subjects were white 
and male. The most common diagnoses were unclassifiable ILD (45%), IPF (34%), hypersensitivity 
pneumonitis (8%), and connective tissue disease ILD (11%). Most elderly subjects (74%) with 
unclassifiable ILD had an imaging pattern inconsistent with usual interstitial pneumonia (UIP). There 
were no significant differences in pulmonary function or three-year mortality between non-elderly and 
elderly subjects combined, or in a subgroup analysis of those with IPF.   
Conclusions: While IPF was the single most common diagnosis, the majority of elderly subjects had non-
IPF ILD. Our findings highlight the need for every patient with new-onset ILD, regardless of age, to be 
surveyed for exposures and findings of connective tissue disease. Unclassifiable ILD was common among 
the elderly, but for most the radiographic pattern was inconsistent with UIP. While the effect of ILD may 
be more pronounced in the elderly due to reduced global functionality, ILD was not more severe or 
aggressive in this group.  
 
 
Introduction 
Interstitial lung disease (ILD) encompasses a spectrum of diffuse fibrotic and inflammatory parenchymal 
injuries. Idiopathic pulmonary fibrosis (IPF) is the ILD most closely related to aging: onset before age 50 
is rare, and the incidence of IPF increases with age.(1) Further, IPF is associated with telomerase 
mutations, indicating it may be related to premature aging.(2, 3) However, beyond the association of IPF 
and aging, the epidemiology of other forms of ILD in the elderly is not known.   
 
Currently in the United States, 14% of the population is 65 years or older, and at age 65 the average life 
expectancy is 19.3 years.(4) With population aging, ILD in the elderly is increasingly encountered in 
clinical practice. In addition, age-related considerations have implications for ILD care. Compared to 
younger patients, the risks of surgical lung biopsy and immunosuppression are higher for elderly 
patients.(5-7) Age may also have an impact on survival in ILD. In a large IPF cohort, older age at disease 
presentation was associated with decreased survival.(8) However, it is not known if ILD is more 
aggressive at the extremes of age, or if age-related co-morbidities contribute to poor outcomes. In this 
prospective study of ILD, we sought to define the diagnoses, clinical characteristics, and outcomes of 
patients who were elderly at the time of ILD presentation.  
 
 
Methods 
This study was approved by the institutional review board of the University of Pennsylvania (protocol 
number 817689) and is HIPPA compliant.  Between 2012 and 2016, patients seen at a tertiary ILD clinic 
associated with a university-based hospital in the mid-Atlantic United States were serially recruited for 
study participation, and enrolled via informed consent. As a referral center for a second opinion or 
consideration of lung transplant, many patients had had their disease for years before the first clinic 
visit. Age of ILD onset was therefore defined as the age at which chest imaging first demonstrated ILD, 
even if onset was before the first visit to our clinic. While a universally accepted definition for “elderly” 
is lacking, age ≥ 65 is generally considered elderly.(9, 10) We used a more conservative age cut-off of 70 
to define elderly for our study. Subjects between 18 and 69 years old comprised our non-elderly cohort.  
Testing 
Chest computed tomography (CT) imaging obtained near the time of the first clinic visit was reviewed by 
a thoracic radiology expert in ILD and blinded to clinical details. Surgical lung biopsies, explanted lungs, 
and autopsy samples were reviewed by a pulmonary pathologist with expertise in ILD. Pulmonary 
function testing (PFT) and a 6-minute walk test performed near the time of CT imaging were interpreted 
according to established criteria.(11) When available, results from yearly follow-up PFT and walk tests 
were also recorded.  A decline in lung function was defined as a 10% or greater decrease in the forced 
vital capacity (FVC), or a 15% or greater decrease in the diffusion capacity (DLCO) in one year. 
Hypoxemia was defined by the need for supplemental oxygen, and/or a saturation < 90% on room air. 
Study-termination outcomes included death or lung transplantation. 
Clinical review   
All subjects underwent a detailed history and physical exam with an emphasis on features discriminating 
between causes of ILD. ILD diagnoses were established by a multi-disciplinary consensus review 
including at least two pulmonologists expert in ILD, a thoracic radiologist, and a pulmonary 
pathologist.(12) IPF was diagnosed according to ATS/ERS/JRS/ALAT criteria.(13) Hypersensitivity 
pneumonitis was most often established by supportive histopathology in the setting of consistent 
clinical features. For subjects unable to undergo lung biopsy, a suggestive clinical presentation with an 
exposure history and imaging features typical for hypersensitivity pneumonitis established the diagnosis. 
Sarcoidosis was diagnosed according to ATS/ERS/WASOG criteria, and only subjects with interstitial 
disease were included in our ILD cohort.(14) A clinical diagnosis of connective tissue disease (CTD) with 
consistent imaging or histopathology for CTD-ILD estabished this diagnosis. In accordance with society 
statements on the diagnosis of idiopathic interstitial pneumonias and IPF, unclassifiable ILD was 
subtyped into categories of (a) inadequate data, (b) discordant data, or (c) “possible usual interstitial 
pneumonia (UIP)”, with radiographic features suggestive of UIP but lacking honeycombing and without 
biopsy for further assessment.(13, 15) ILD due to chronic aspiration was diagnosed by imaging findings 
of lower lobe bronchiolitis with documented tracheal aspiration on a barium swallow study, and without 
an alternative diagnosis to better account for ILD.   
 
Statistical analysis 
Study data were collected and managed using Research Electronic Data Capture (REDCap) electronic 
data capture tools hosted at the University of Pennsylvania.(16) Comparisons between groups were 
made using a chi-square test for categorical data, and a one-way analysis of variance for continuous 
data. For all tests, a p-value < 0.05 determined significance. Data analysis was performed using STATA 
software (statacorp version 13.1). 
 
Results 
Demographics  
Of the 327 subjects enrolled, 80 (24%) were elderly. Nearly all elderly subjects were white (94%) and 
most were male (68%) (Table 1). The non-elderly group was significantly more diverse. Surgical lung 
biopsies were uncommon (9%) among the elderly. 
 
ILD subtypes as a function of age 
The relative incidence of ILDs changes with age (Figure 1a). Sarcoidosis and CTD-ILD accounted for a 
large percentage of ILD in younger individuals. In the elderly, there were no new cases of sarcoidosis, yet 
otherwise a variety of ILDs were encountered in this group (Figure 1b). While unclassifiable disease 
(45%) and IPF (34%) were most common, the burden from CTD-ILD (11%) and hypersensitivity 
pneumonitis (8%) were also significant. Other causes accounted for 3% of ILD in the elderly, and 
included one case each of asbestosis and chronic aspiration.  
 
It is often suggested that many cases of unclassifiable ILD in the elderly represent undiagnosed IPF.  
However, in our cohort, only 26% of elderly subjects with unclassifiable ILD had imaging features 
consistent with “possible UIP”. Of the remainder, 59% had inadequate or non-specific data, and 15% had 
discordant data. In conjunction with a CT scan not diagnostic of UIP, lack of a surgical lung biopsy was 
the primary reason data was inadequate, where only 1 out of 20 of these elderly subjects had 
undergone a surgical lung biopsy. In contrast, all subjects had undergone a basic exposure and review of 
systems survey, and most (78%) had undergone a serologic assessment, reducing the likelihood of 
connective tissue disease and hypersensitivity pneumonitis as causes of ILD in this group.   
 
Disease severity  
Nearly all subjects (93%) had PFT data to review, and all subjects in the study were assessed for 
hypoxemia. Functional deficits in lung function and rates of hypoxemia were similar between the two 
age groups (Figure 2). Results from a 6-minute walk test were available for 235 subjects (72%). The 
elderly cohort had a lower average walk distance (320 meters vs. 370 meters, p=0.02), and was 
significantly more likely to be hypoxemic (40% vs. 26%, p=0.01) compared to the non-elderly cohort. 
 
To evaluate the effect of age in a more disease-specific fashion, indices of disease severity for elderly 
and non-elderly subjects with IPF were compared in a subgroup analysis. Nearly all subjects (96%) with 
IPF had PFT data, and most (82%) had walk test data to review. No significant differences in FVC 
(p=0.50), DLCO (p=0.42), walk distances (p=0.11), or rates of hypoxemia (p=0.29) were noted between 
non-elderly and elderly subjects with IPF (Table 2).  
 
Long-term outcomes  
At the time of this study, nearly all subjects (98%) had had their ILD for at least a year. Of those, 195 had 
one-year FVC data available for review. Fewer subjects (43%) had one-year DLCO data. Among those 
with follow-up data, the frequency of pulmonary function decline in the first year was similar in the 
elderly and non-elderly (Table 3). The frequency of pulmonary function decline in IPF in particular also 
was similar in the elderly and non-elderly (Table 3).  
 
Among the 251 subjects who had been diagnosed with ILD three or more years prior to the time of this 
study, 151 subjects were confirmed alive, 8 had died, and 6 had undergone lung transplant within 3 
years of their diagnosis. Eighty-six subjects were lost to follow-up or did not have full clinical data to 
review at 3 years. Only a minority (17%) of subjects in our cohort who have undergone lung transplant 
was elderly at the time of disease onset. Excluding subjects with insufficient data, 3-year mortality rates 
were not different between elderly and non-elderly subjects (p=0.79) (Table 3). While 3-year mortality 
rates were higher for those with IPF compared to non-IPF ILD (13% vs. 6%), IPF mortality rates were not 
higher for elderly compared to non-elderly subjects (p=0.38) (Table 3).  
 
Discussion 
Most elderly subjects with new-onset ILD were men, and nearly all were white. Historically, higher 
incidences of smoking and occupational exposures have predisposed men more than women to certain 
ILDs. It is possible that these factors contribute to the male predominance observed in our elderly 
cohort. Similar to findings in previous reports on the epidemiology of IPF, no elderly subjects with IPF in 
our study were black and only a small percentage of all elderly subjects with ILD were black.(17, 18) Yet, 
by recent census data, blacks account for 6.1% of people 65 and older in the United States, and a 
sizeable percentage of patients served by our institution are black. The reason for the disproportionately 
low prevalence of IPF among blacks is unknown. 
 
Due to the strong association of IPF with advanced age, it may be assumed that IPF accounts for the 
majority of new-onset ILD in the elderly. However, our data contradict this assertion, where IPF 
accounted for only 34% of new-onset ILD in an elderly cohort.  Other ILDs, such as unclassifiable ILD not 
resembling UIP (33%), CTD-ILD (11%), and hypersensitivity pneumonitis (8%), were common among the 
elderly. Thus, like their non-elderly counterparts, elderly patients with ILD should be surveyed for 
exposures and for extra-thoracic findings indicative of connective tissue disease.   
 
A radiographic pattern of “possible UIP” is very often found to be UIP if histologic sampling is 
pursued.(19) Indeed, this may be particularly the case for elderly subjects, where Fell and colleagues 
found that nearly all patients older than 70 with fibrotic reticulations but lacking radiographic 
honeycombing had UIP on histopathology, and were given a diagnosis of IPF.(20) However, among our 
elderly subjects with unclassifiable ILD, only a minority (26%) met radiographic criteria for “possible 
UIP”. Our interest, therefore, centers around the 74% of elderly subjects with unclassifiable ILD who had 
a radiographic pattern inconsistent with UIP. While we suspect that many of these subjects have a 
disease other than IPF, it is known that some patients with radiographs inconsistent with UIP will be 
given a diagnosis of IPF if lung biopsies are interpreted as diagnostic of UIP. In a study of patients pre-
selected for having biopsy-established UIP, nearly a third had a CT pattern inconsistent with UIP.(21) 
This underscores the necessity for surgical lung biopsy when medically feasible in elderly subjects with 
unclassifiable ILD, even as the prevalence of UIP among all comers with an imaging pattern inconsistent 
with UIP is unknown. Given that at least some portion of these patients will have discordant 
radiographic-histologic UIP, and in light of the recent approval of therapies for IPF, the risk-benefit ratio 
of undergoing a surgical lung biopsy, even in elderly patients, may shift in favor of biopsy. 
 
Minor “interstitial changes” are commonly identified on CT scans of older patients. In one study, limited-
extent peripheral reticulations on CT imaging were noted in 60% of asymptomatic patients older than 
75.(22) Therefore, it might be suspected that a large percentage of our unclassifiable ILD represents 
incidentally identified, clinically irrelevant interstitial findings. However, nearly all of our subjects had 
objective measures of abnormal lung function. Finally, it is possible that some of the unclassifiable ILD in 
the elderly represents aspiration related scarring.(23) It is well known that the incidence of aspiration 
increases with age.(24, 25) It is unclear, however, whether aspiration results in clinically relevant 
interstitial fibrosis. Further studies to characterize the features and outcomes of unclassifiable disease in 
the elderly and non-elderly alike are needed.   
 
In general, the impact of diseases is often greater for older compared to younger patients.  We were 
surprised to see that this was largely not the case with ILD in our population. Functional deficits, rates of 
decline, and mortality were not significantly different between the elderly and non-elderly. While the 
walk distance was lower in the elderly, this test is an indirect measure of ILD severity, and its 
determinants are multi-factorial. Therefore, hypoxemia was the only functional measure directly related 
to ILD that was worse in the elderly population.  
 
Prior studies have suggested that mortality in patients with IPF is related to age at disease onset.(8) Yet, 
we found that key measures of disease including lung function, rates of hypoxemia, and long-term 
outcomes, including mortality, were similar for non-elderly and elderly subjects with IPF. Larger cohort 
data utilizing updated diagnostic criteria, and with sufficient follow-up periods, will further clarify the 
effect of age on the disease course in IPF.  
 
There are several limitations of this study. Surgical lung biopsies were rare among our elderly subjects, 
which may account for the high burden of unclassifiable disease in this age group. The risk-benefit ratio 
of a surgical lung biopsy in older patients is often unfavorable, where rates of co-morbidities and 
surgical risks are higher.(5) Not all subjects yet have follow-up data available for review, which limited a 
full assessment of the natural history of ILD in the elderly. In addition, as a tertiary referral center, the 
possibility of referral bias is acknowledged. In particular, our cohort may be enriched for patients with 
atypical features, including atypical radiographic patterns, which will limit the generalizability of our 
findings. Finally we acknowledge our small sample size as a limitation, which may have influenced the 
results of our analysis of disease progression. We plan to replicate these findings in a larger population 
as the study is ongoing. 
 
To our knowledge, this study is the first to characterize the causes and clinical features of ILD in an 
elderly population. As expected, IPF was the single most commonly diagnosed ILD in the elderly.  
However, it was not expected that over half of elderly patients would have an ILD other than IPF, and 
that a variety of ILDs would be present among this group, including CTD-ILD and hypersensitivity 
pneumonitis. ILD severity and rates of progression were similar between the elderly and non-elderly, 
suggesting that a patient’s overall functional status and ILD subtype should factor into prognostication 
more than age. As life expectancy continues to increase, more studies to further clarify the impact and 
natural history of ILD in the elderly are important. 
 Table 1 Clinical characteristics of non-elderly and elderly subjects with ILD  
Table 2 Disease severity by age groups for all ILD combined and for IPF 
Table 3 Outcomes by age groups for all ILD combined and for IPF 
 
Figure 1: Distribution of ILD diagnoses by age. The relative occurrence of ILDs across the full range of 
ages is demonstrated in Figure 1a. The numbers of ILD diagnoses in the non-elderly and elderly groups 
are shown in Figure 1b. Sarcoidosis was common among the non-elderly, but there were no cases of 
new-onset sarcoidosis in the elderly. The proportion of IPF and unclassifiable ILD increased with age. 
However, new-onset CTD-ILD and hypersensitivity pneumonitis combined also constituted a sizeable 
minority of ILD in the elderly.  
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